Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer membrane permeability enhancement refers to strategies or mechanisms that increase the permeability of the outer membrane (OM) of Gram-negative bacteria. The OM acts as a selective barrier, protecting bacteria from harmful agents, including antibiotics, by limiting their entry into the cell. Enhancing OM permeability is a key approach in overcoming bacterial resistance and improving antibiotic efficacy. Mechanisms include disruption via polycations/chelators and efflux pump inhibition.
Disruption of outer membrane integrity via LPS interaction or efflux pump inhibition, leading to increased antibiotic permeability.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer Membrane Permeability Enhancement.